New York cancer death rates plummet, biggest drop among Black residents
The biggest decline was among non-Hispanic Black residents. Their cancer death rate dropped from 245.1 to 124, a 49.4% ...
News Medical7h
Access to accredited hospitals improves cancer care outcomes for vulnerable patients
Vulnerable patients facing social, environmental, and economic disadvantages often experience worse cancer outcomes than other groups.
Drug Deaths Are Finally Declining. Nobody Really Knows Why.
Drug warriors do not deserve credit for the turnaround, although they deserve blame for the previous explosion in fatal ...
Report: Cancer deaths have dropped, but alcohol is factor in new cases
Scientific advances helped avert 4.1 million deaths from cancer in the 30 years between 1991 and 2021 according to a new ...
Vulnerable patients have a decreased mortality risk when treated at commission on cancer-accredited hospitals
Vulnerable patients facing social, environmental, and economic disadvantages often experience worse cancer outcomes than ...
scrippsnews15h
Cancer mortality in the US is on the decline, annual report finds
The American Association for Cancer Research has released its 2024 Cancer Progress Report, which tracks advancements in ...
US overdoses have fallen sharply in recent months, a hopeful shift in trends
Federal data shows that overdose deaths in the United States are the lowest they’ve been in three years, and a new analysis ...
Becker's Hospital Review1d
33% decline in cancer death rate: 12 things to know
Forty percent of all cancers are associated with modifiable risk factors, though there has been a 33% decline in the cancer death rate between 1991 and 2021, according to the American Association for ...
dermatologyadvisor1d
Melanoma Incidence, Mortality Declining in Those Aged 30 to 49 Years
For adults aged 30 to 49 years, there has been a decline in melanoma incidence and mortality, according to study findings.
Cancer deaths in U.S. fell by 33% in 30 years, but alcohol remains a lesser-known risk factor
The latest Cancer Progress Report from the American Association for Cancer Research also found a 24% decline in the overall ...
Endocrinology Advisor3d
PSA Changes During 177Lu-PSMA-617 Therapy Predict mCRPC Outcomes
Not only does lutetium-177-PSMA-617 lower PSA levels in men with metastatic prostate cancer (mCRPC), PSA decline correlates with outcomes, research shows.